MRP ₹94
(Inclusive of all Taxes)
₹14.1 Cashback (15%)
Extra 15% Off with Bank Offers
Composition :
BUPIVACAINE-5MG
Manufacturer/Marketer :
Troikaa Pharmaceuticals Ltd
Consume Type :
Parenteral
Expires on or after :
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Pregnancy
Breast Feeding
Driving
Liver
Kidney
Children
Product Substitutes
Drug-Drug Interactions
BupivacaineEtidocaine
Severe
Severe
Drug-Drug Interactions
Login/Sign Up
BupivacaineEtidocaine
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Combining Bupitroy 0.5% Injection 20 ml with etidocaine can have additive toxic effects, so using them together increases the risk of serious side effects like methemoglobinemia (a condition that can deprive tissues and organs of oxygen), reactions in the central nervous system (e.g-convulsions, unconsciousness, coma, respiratory arrest), and cardiovascular disorders (e.g- low blood pressure, heart block, irregular heart rhythm).
How to manage the interaction:
Although there is a possible interaction between Etidocaine and Bupitroy 0.5% Injection 20 ml, you can take these medicines together if prescribed by your doctor. However, if you experience pale, grey, or blue-coloured skin, headache, rapid heart rate, shortness of breath, lightheadedness, or fatigue, consult a doctor. Do not stop using any medications without consulting a doctor.
Combining Bupitroy 0.5% Injection 20 ml with etidocaine can have additive toxic effects, so using them together increases the risk of serious side effects like methemoglobinemia (a condition that can deprive tissues and organs of oxygen), reactions in the central nervous system (e.g-convulsions, unconsciousness, coma, respiratory arrest), and cardiovascular disorders (e.g- low blood pressure, heart block, irregular heart rhythm).
How to manage the interaction:
Although there is a possible interaction between Etidocaine and Bupitroy 0.5% Injection 20 ml, you can take these medicines together if prescribed by your doctor. However, if you experience pale, grey, or blue-coloured skin, headache, rapid heart rate, shortness of breath, lightheadedness, or fatigue, consult a doctor. Do not stop using any medications without consulting a doctor.
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Taking Bupitroy 0.5% Injection 20 ml and Flutamide may cause methemoglobinemia, (a condition in which the iron in the hemoglobin molecule -the red blood pigment is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and Flutamide together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Bupitroy 0.5% Injection 20 ml and Flutamide may cause methemoglobinemia, (a condition in which the iron in the hemoglobin molecule -the red blood pigment is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and Flutamide together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Taking Bupitroy 0.5% Injection 20 ml with rasburicase can increase the risk of methemoglobinemia(blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Taking Bupitroy 0.5% Injection 20 ml with Rasburicase together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Bupitroy 0.5% Injection 20 ml with rasburicase can increase the risk of methemoglobinemia(blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Taking Bupitroy 0.5% Injection 20 ml with Rasburicase together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
BupivacaineNitric oxide
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Taking Bupitroy 0.5% Injection 20 ml and Nitric oxide may cause methemoglobinemia, (a condition in which the iron in the hemoglobin molecule -the red blood pigment is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and nitric oxide together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Bupitroy 0.5% Injection 20 ml and Nitric oxide may cause methemoglobinemia, (a condition in which the iron in the hemoglobin molecule -the red blood pigment is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and nitric oxide together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Taking Bupitroy 0.5% Injection 20 ml with chloroquine may cause methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and chloroquine together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Bupitroy 0.5% Injection 20 ml with chloroquine may cause methemoglobinemia (blood disorder in which too little oxygen is delivered to your cells).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and chloroquine together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Coadministration of Bupitroy 0.5% Injection 20 ml and sulfasalazine may result in methemoglobinemia, an uncommon disorder that lowers the blood's ability to carry oxygen, which can induce oxygen deprivation in tissues and essential organs.
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and sulfasalazine together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as grey discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Coadministration of Bupitroy 0.5% Injection 20 ml and sulfasalazine may result in methemoglobinemia, an uncommon disorder that lowers the blood's ability to carry oxygen, which can induce oxygen deprivation in tissues and essential organs.
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and sulfasalazine together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as grey discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Coadministration of Bupitroy 0.5% Injection 20 ml and Metoclopramide can increase the risk of methemoglobinemia (a condition in which the iron in the hemoglobin molecule (the red blood pigment) is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although there is a possible interaction between metoclopramide and Bupitroy 0.5% Injection 20 ml, you can take these medicines together if prescribed by a doctor. However, if you experience symptoms such as grey discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Coadministration of Bupitroy 0.5% Injection 20 ml and Metoclopramide can increase the risk of methemoglobinemia (a condition in which the iron in the hemoglobin molecule (the red blood pigment) is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although there is a possible interaction between metoclopramide and Bupitroy 0.5% Injection 20 ml, you can take these medicines together if prescribed by a doctor. However, if you experience symptoms such as grey discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Taking Bupitroy 0.5% Injection 20 ml and Ifosfamide may cause methemoglobinemia, (a condition in which the iron in the hemoglobin molecule -the red blood pigment is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and ifosfamide together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Bupitroy 0.5% Injection 20 ml and Ifosfamide may cause methemoglobinemia, (a condition in which the iron in the hemoglobin molecule -the red blood pigment is defective, making it unable to carry oxygen effectively to the tissues).
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and ifosfamide together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience symptoms such as gray discoloration of the skin, abnormal blood coloration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
BupivacaineMepivacaine
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Combining Bupitroy 0.5% Injection 20 ml with Mepivacaine can have additive toxic effects, so using them together increases the risk of serious side effects like methemoglobinemia (a condition that can deprive tissues and organs of oxygen), reactions in the central nervous system (e.g-convulsions, unconsciousness, coma, respiratory arrest), and cardiovascular disorders (e.g- low blood pressure, heart block, irregular heart rhythm).
How to manage the interaction:
Although taking Mepivacaine and Bupitroy 0.5% Injection 20 ml together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience pale, grey, or blue-coloured skin, headache, rapid heart rate, shortness of breath, lightheadedness, or fatigue, consult a doctor. Do not stop using any medications without first talking to your doctor.
Combining Bupitroy 0.5% Injection 20 ml with Mepivacaine can have additive toxic effects, so using them together increases the risk of serious side effects like methemoglobinemia (a condition that can deprive tissues and organs of oxygen), reactions in the central nervous system (e.g-convulsions, unconsciousness, coma, respiratory arrest), and cardiovascular disorders (e.g- low blood pressure, heart block, irregular heart rhythm).
How to manage the interaction:
Although taking Mepivacaine and Bupitroy 0.5% Injection 20 ml together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience pale, grey, or blue-coloured skin, headache, rapid heart rate, shortness of breath, lightheadedness, or fatigue, consult a doctor. Do not stop using any medications without first talking to your doctor.
Severe
How does the drug interact with Bupitroy 0.5% Injection 20 ml:
Taking Mexiletine with Bupitroy 0.5% Injection 20 ml may cause serious side effects including methemoglobinemia, a serious blood disorder in which too little oxygen is delivered to your cells and heart problems.
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and mexiletine together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, consult a doctor immediately if you develop pale, grey, or blue-coloured skin, abnormal blood colouration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, Jerking movements of the arms and legs, Loss of consciousness, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without talking to a doctor.
Taking Mexiletine with Bupitroy 0.5% Injection 20 ml may cause serious side effects including methemoglobinemia, a serious blood disorder in which too little oxygen is delivered to your cells and heart problems.
How to manage the interaction:
Although taking Bupitroy 0.5% Injection 20 ml and mexiletine together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, consult a doctor immediately if you develop pale, grey, or blue-coloured skin, abnormal blood colouration, nausea, headache, dizziness, lightheadedness, fatigue, shortness of breath, Jerking movements of the arms and legs, Loss of consciousness, rapid or shallow breathing, a rapid heartbeat, palpitation, anxiety, or confusion. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Diseases Interactions
Login/Sign Up
All Substitutes & Brand Comparisons
RX
Not for online saleBupicain-0.5% Injection 20 ml
Themis Pharmaceutical Ltd
₹92.5
(₹4.17/ 1ml)
1% CHEAPERRX
Out of StockNot for online saleBupifix 0.5% Injection 20 ml
VARENYAM HEALTHCARE PVT LTD
₹97.2
(₹4.37/ 1ml)
3% COSTLIERRX
Out of StockBupibloc 0.5% Injection 20 ml
Samarth Life Sciences Pvt Ltd
₹97.44
(₹4.39/ 1ml)
3% COSTLIER
Have a query?